Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Acquisitions & Divestments (2024 - 2025)

Beta Bionics' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $48.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 200.0% year-over-year to $48.0 million; the TTM value through Dec 2025 reached $170.0 million, up 136.11%, while the annual FY2025 figure was $170.0 million, 136.11% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $48.0 million at Beta Bionics, down from $71.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $71.0 million in Q3 2025 and bottomed at $8.0 million in Q1 2024.